How much to invest in evidence-based, cost-effective prevention?

Moral injury in clinicians concerning in COVID-19 “war”

Case for mandatory notification of invasive Strep A disease

Managing multiple patient concerns in a GP consultation

Sydney avoids 4000 cases, but lockdown must be broadened

Mitral valve disease: minimally invasive fix now on MBS

Corporate rewards tobacco company as supplier of the year

Legal restrictions to cross-sex hormone treatment for under 18s

Equal access to glucose monitoring vital to flattening diabetes curve

Improving Australian quarantine – insights from Hong Kong

Doctors need to lead and design health services

Chemical restraint: legislative changes to “restrictive practices”